Gastrointestinal Cancer

Gastric cancer (GC) is a malignant tumor with one of the lowest five-year survival rates. Traditional first-line treatment regimens, such as platinum drugs, have limited therapeutic efficacy in treating advanced GC and significant side effects …

The introduction of colorectal cancer (CRC) screening programs has resulted in an increase in the detection of early-stage cancers. The indication for endoscopic treatment of CRC is limited to submucosal invasive (T1) cancer, while surgical …

Endoscopic ultrasonography (EUS) provides high spatial resolution and more detailed images than other diagnostic modalities. Furthermore, EUS-guided tissue acquisition (EUS-TA), such as EUS-guided fine needle aspiration or biopsy (EUS-FNA/FNB), is …

Pancreatic cancer is an exceptionally lethal malignancy for which mortality closely parallels incidence [ 1 ]. Due to the lack of early symptoms coupled with the unavailability of early efficient non-invasive screening and diagnostic markers …

Although epidemiologic data to analyze disparities in gastrointestinal (GI) cancer incidence, prevalence, and mortality among sexual and gender minority (SGM) individuals is limited [ 1 ], it is well known that risk factors for GI cancers, such as …

Gastric cancer (GC) is a malignant tumor with one of the lowest five-year survival rates. Traditional first-line treatment regimens, such as platinum drugs, have limited therapeutic efficacy in treating advanced GC and significant side effects …

Esophageal cancer is the seventh leading cause of cancer mortality worldwide. Esophageal squamous-cell carcinoma (ESCC) is the most common histological subtype of esophageal cancer, accounting for approximately 90% of all cases worldwide [ 1 , 2 ].

This Delphi consensus study was conducted between June 2022 and June 2023. The Delphi method is a structured iterative survey-based technique to facilitate collective decision making and capture the breadth of expert opinions in a systematic …